These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14583690)

  • 1. Mapping the SF-12 to preference-based instruments: convergent validity in a low-income, minority population.
    Franks P; Lubetkin EI; Gold MR; Tancredi DJ
    Med Care; 2003 Nov; 41(11):1277-83. PubMed ID: 14583690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States.
    Luo N; Johnson JA; Shaw JW; Coons SJ
    Med Care; 2009 Jan; 47(1):53-60. PubMed ID: 19106731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease.
    Luo N; Chew LH; Fong KY; Koh DR; Ng SC; Yoon KH; Vasoo S; Li SC; Thumboo J
    J Rheumatol; 2003 Oct; 30(10):2268-74. PubMed ID: 14528528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression.
    Abdin E; Chong SA; Seow E; Tan KB; Subramaniam M
    BMC Psychiatry; 2021 Sep; 21(1):451. PubMed ID: 34517871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings.
    Shiroiwa T; Noto S; Fukuda T
    Value Health; 2021 Aug; 24(8):1193-1202. PubMed ID: 34372985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EQ-5D in skin conditions: an assessment of validity and responsiveness.
    Yang Y; Brazier J; Longworth L
    Eur J Health Econ; 2015 Dec; 16(9):927-39. PubMed ID: 25358263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Eur J Health Econ; 2020 Jun; 21(4):501-511. PubMed ID: 31902023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
    Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
    Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia.
    Seow LSE; Lau JH; Abdin E; Verma SK; Tan KB; Subramaniam M
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):813-821. PubMed ID: 37216213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.
    Luo N; Johnson JA; Shaw JW; Feeny D; Coons SJ
    Med Care; 2005 Nov; 43(11):1078-86. PubMed ID: 16224300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
    Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
    Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample.
    Lawrence WF; Fleishman JA
    Med Decis Making; 2004; 24(2):160-9. PubMed ID: 15090102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the SF-12 to the EuroQol EQ-5D Index in a national US sample.
    Franks P; Lubetkin EI; Gold MR; Tancredi DJ; Jia H
    Med Decis Making; 2004; 24(3):247-54. PubMed ID: 15185716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study.
    Leung YY; Png ME; Wee HL; Thumboo J
    J Rheumatol; 2013 Jun; 40(6):859-65. PubMed ID: 23504382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
    Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
    Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.